US FDA Looks To Resume Unannounced Inspections In India And China
After lapsing due to COVID-19, an unannounced foreign inspection pilot program is on track to resume in 2022, “despite challenges and constraints of travel.”
You may also be interested in...
US Forming Industry Consortia To Prepare For Future Pandemics And Global Supply Chain Disruptions
HHS agencies look to build on COVID-19 experience by developing quicker public/private responses to pandemics and supply chain threats.
US FDA’s In-Person Foreign Inspections Remain On House Appropriators’ Minds
The House Appropriations Committee also does not want the agency to become too dependent on alternative inspection tools.
India’s COVID-19 Surge Forced Another Abrupt Stop Of US FDA In-Person Inspections
Agency inspectors worked in the country for about a month before the coronavirus infection surge forced another halt.